The widely studied methyltransferase, enhancer of zeste homolog 2 (EZH2, the subunit of multi-comb inhibitory complex 2 [PRC2]), whose inhibitors have been used in tumor therapy, participates in gene expression silencing by catalyzing H3K27me3 [34]. This evidence concerns the gene EZH2 and neoplasm.